Join
Live feed
·
PRReleasevia Quantisnow
Quantum Biopharma Ltd. logo

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

ByQuantisnow·Wall Street's wire, on your screen.
QNTM· Quantum Biopharma Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QNTM (Quantum Biopharma Ltd.) and more on Quantisnow.